Patent foramen ovale closure for secondary prevention of cryptogenic stroke

References

• Cohnheim J. Untersuchungen über die embolischen Processe. Hirschwald. 1872.
   Google Scholar
• Moore KLP, T VM. The developing human: clinically oriented embryology. Philadelphia: Saunders; 1994.
   Google Scholar
• Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005;112(7):1063–1072.
   PubMed Web of Science ®Google Scholar
• Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318(18):1148–1152. .
   PubMed Web of Science ®Google Scholar
• Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet. 1988;2(8601):11–12. .
   PubMed Web of Science ®Google Scholar
• Kim SJ, Shin HY, Ha YS, et al. Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (identification of the cause of silent cerebral infarction in healthy subjects). Eur J Neurol. 2013;20(2):353–360. .
   PubMed Web of Science ®Google Scholar
• Homma S, Sacco RL, Di Tullio MR, et al. Investigators PFOiCSS. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation. 2002;105(22):2625–2631.
   PubMed Web of Science ®Google Scholar
• Steiner MM, Di Tullio MR, Rundek T, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke. 1998;29(5):944–948. .
   PubMed Web of Science ®Google Scholar
• Schuchlenz HW, Saurer G, Weihs W, et al. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr. 2004;17(3):231–233.
   PubMed Web of Science ®Google Scholar
• Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345(24):1740–1746. .
   PubMed Web of Science ®Google Scholar
• De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31(10):2407–2413. .
   PubMed Web of Science ®Google Scholar
• Stone DA, Godard J, Corretti MC, et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J. 1996;131(1):158–161. .
   PubMed Web of Science ®Google Scholar
• Landzberg MJ, Khairy P. Indications for the closure of patent foramen ovale. Heart. 2004;90(2):219–224.
   PubMed Web of Science ®Google Scholar
• Stollberger C, Slany J, Schuster I, et al. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med. 1993;119(6):461–465.
   PubMed Web of Science ®Google Scholar
• Greer DM, Buonanno FS. Cerebral infarction in conjunction with patent foramen ovale and May-Thurner syndrome. J Neuroimaging. 2001;11(4):432–434.
   PubMed Web of Science ®Google Scholar
• Kiernan TJ, Yan BP, Cubeddu RJ, et al. May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke. 2009;40(4):1502–1504. .
   PubMed Web of Science ®Google Scholar
• Konstantinides S, Geibel A, Kasper W, et al. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation. 1998;97(19):1946–1951.
   PubMed Web of Science ®Google Scholar
• Ng PY, Ng AK, Subramaniam B, et al. Association of preoperatively diagnosed patent foramen ovale with perioperative ischemic stroke. JAMA. 2018;319(5):452–462. .
   PubMed Web of Science ®Google Scholar
• Hamann GF, Schatzer-Klotz D, Frohlig G, et al. Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology. 1998;50(5):1423–1428. .
   PubMed Web of Science ®Google Scholar
• Pristipino C, Sievert H, D’Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2019;40(38):3182–3195.
   PubMed Web of Science ®Google Scholar
• Mojadidi MK, Bogush N, Caceres JD, et al. Diagnostic accuracy of transesophageal echocardiogram for the detection of patent foramen ovale: a meta-analysis. Echocardiography. 2014;31(6):752–758.
   PubMed Web of Science ®Google Scholar
• Katsanos AH, Psaltopoulou T, Sergentanis TN, et al. Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta-analysis. Ann Neurol. 2016;79(4):625–635. .
   PubMed Web of Science ®Google Scholar
• Mojadidi MK, Roberts SC, Winoker JS, et al. Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective studies. JACC Cardiovasc Imaging. 2014;7(3):236–250. .
   PubMed Web of Science ®Google Scholar
• Messe SR, Gronseth GS, Kent DM, et al. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the guideline subcommittee of the American academy of neurology. Neurology. 2020;94(20):876–885. .
   PubMed Web of Science ®Google Scholar
• Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345(20):1444–1451. .
   PubMed Web of Science ®Google Scholar
• Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002;106(9):1121–1126. .
   PubMed Web of Science ®Google Scholar
• Inglessis I, Elmariah S, Rengifo-Moreno PA, et al. Long-term experience and outcomes with transcatheter closure of patent foramen ovale. JACC Cardiovasc Interv. 2013;6(11):1176–1183. .
   PubMed Web of Science ®Google Scholar
• Agarwal S, Bajaj NS, Kumbhani DJ, et al. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism. JACC Cardiovasc Interv. 2012;5(7):777–789.
   PubMed Web of Science ®Google Scholar
• Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation. 2000;101(8):893–898. .
   PubMed Web of Science ®Google Scholar
• Diaz T, Cubeddu RJ, Rengifo-Moreno PA, et al. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up. Catheter Cardiovasc Interv. 2010;76(1):145–150. .
   PubMed Web of Science ®Google Scholar
• Susuri N, Obeid S, Ulmi M, et al. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale. EuroIntervention. 2017;13(7):858–866. .
   PubMed Web of Science ®Google Scholar
• Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991–999. .
   PubMed Web of Science ®Google Scholar
• Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092–1100. .
   PubMed Web of Science ®Google Scholar
• Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083–1091. .
   PubMed Web of Science ®Google Scholar
• Rengifo-Moreno P, Palacios IF, Junpaparp P, et al. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J. 2013;34(43):3342–3352.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou K, Hua Y, et al. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect. Cardiol Young. 2013;23(4):582–596. .
   PubMed Web of Science ®Google Scholar
• Elmariah S, Furlan AJ, Reisman M, et al. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex septal closure system in patients with a stroke and/or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale) trial. JACC Cardiovasc Interv. 2014;7(8):913–920. .
   PubMed Web of Science ®Google Scholar
• Mas JL, Derumeaux G, Guillon B, et al., Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 377(11): 1011–1021. 2017.
   PubMed Web of Science ®Google Scholar
• Sondergaard L, Kasner SE, Rhodes JF, et al., Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 377(11): 1033–1042. 2017.
   PubMed Web of Science ®Google Scholar
• Lee PH, Song JK, Kim JS, et al., Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol. 71(20): 2335–2342. 2018.
   PubMed Web of Science ®Google Scholar
• Saver JL, Carroll JD, Thaler DE, et al., Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 377(11): 1022–1032. 2017.
   PubMed Web of Science ®Google Scholar
• Turc G, Calvet D, Guerin P, et al., Closure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE study. J Am Heart Assoc. 7(12): e008356. 2018.
   PubMed Web of Science ®Google Scholar
• Elgendy AY, Elgendy IY, Mojadidi MK, et al., New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials. EuroIntervention. 14(17): 1788–1790. 2019.
   PubMed Web of Science ®Google Scholar
• Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004;43(2):302–309. .
   PubMed Web of Science ®Google Scholar
• Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356(9242):1648–1651.
   PubMed Web of Science ®Google Scholar
• Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol. 2003;16(1):39–42.
   PubMedGoogle Scholar
• Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004;62(8):1399–1401. .
   PubMed Web of Science ®Google Scholar
• Post MC, Thijs V, Herroelen L, et al. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology. 2004;62(8):1439–1440.
   PubMed Web of Science ®Google Scholar
• Azarbal B, Tobis J, Suh W, et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol. 2005;45(4):489–492.
   PubMed Web of Science ®Google Scholar
• Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005;45(4):493–495. .
   PubMed Web of Science ®Google Scholar
• Giardini A, Donti A, Formigari R, et al. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J. 2006;151(4):e921–925. 922. .
   Web of Science ®Google Scholar
• Anzola GP, Frisoni GB, Morandi E, et al. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke. 2006;37(2):430–434.
   PubMed Web of Science ®Google Scholar
• Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology. 1999;52(8):1622–1625.
   PubMed Web of Science ®Google Scholar
• Domitrz I, Mieszkowski J, Kwiecinski H. [The prevalence of patent foramen ovale in patients with migraine]. Neurol Neurochir Pol. 2004;38(2):89–92.
   PubMedGoogle Scholar
• Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia. 2008;28(5):531–540.
   PubMed Web of Science ®Google Scholar
• Ozge A, Ozge C, Ozturk C, et al. The relationship between migraine and atopic disorders-the contribution of pulmonary function tests and immunological screening. Cephalalgia. 2006;26(2):172–179. .
   PubMed Web of Science ®Google Scholar
• Gorji A. Spreading depression: a review of the clinical relevance. Brain Res Brain Res Rev. 2001;38(1–2):33–60.
   PubMed Web of Science ®Google Scholar
• Olesen J, Friberg L, Olsen TS, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain. 1993;116(Pt 1):187–202. .
   PubMedGoogle Scholar
• Venketasubramanian N, Sacco RL, Di Tullio M, et al. Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology. 1993;43(8):1533–1535.
   PubMed Web of Science ®Google Scholar
• Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117(11):1397–1404. .
   PubMed Web of Science ®Google Scholar
• Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J. 2016;37(26):2029–2036. .
   PubMed Web of Science ®Google Scholar
• Tobis JM, Charles A, Silberstein SD, et al. Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM Trial. J Am Coll Cardiol. 2017;70(22):2766–2774. .
   PubMed Web of Science ®Google Scholar
• Meier B, Nietlispach F. The evil of the patent foramen ovale: we are seeing but the tip of the iceberg. Eur Heart J. 2018;39(18):1650–1652.
   PubMed Web of Science ®Google Scholar
• Elgendy AY, Saver JL, Amin Z, et al., Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurol. 77(7): 878–886. 2020.
   PubMed Web of Science ®Google Scholar